Urokinase receptor forms in serum from non-small cell lung cancer patients: relation to prognosis

Research output: Contribution to journal › Journal article › Research › peer-review

  • Charlotte Elberling Almasi
  • Ib Jarle Christensen
  • Gunilla Høyer-Hansen
  • Keld Danø
  • Pappot, Helle
  • Hendrik Dienemann
  • Thomas Muley
To study the prognostic impact of the different forms of the receptor for urokinase plasminogen activator (uPAR) in serum from 171 non-small cell lung cancer (NSCLC) patients.
Original languageEnglish
JournalLung Cancer
Volume74
Issue number3
Pages (from-to)510-515
ISSN0169-5002
DOIs
Publication statusPublished - Dec 2011

    Research areas

  • Adult, Aged, Aged, 80 and over, Carcinoma, Non-Small-Cell Lung, Female, Humans, Immunoassay, Male, Middle Aged, Plasminogen Activators, Prognosis, Urokinase-Type Plasminogen Activator

ID: 40148396